Published in Pediatrics on March 01, 2003
Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med (2006) 1.54
Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). J Pediatr (2014) 1.42
Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity. Am J Physiol Lung Cell Mol Physiol (2009) 1.41
Neonatal pulmonary hypertension. Pediatr Crit Care Med (2010) 1.40
Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc (2014) 1.19
Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies? Pediatrics (2011) 1.08
The role of nitric oxide synthase-derived reactive oxygen species in the altered relaxation of pulmonary arteries from lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol (2007) 1.08
Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr (2011) 1.08
Future applications of antioxidants in premature infants. Curr Opin Pediatr (2011) 1.03
Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease? Arch Dis Child Fetal Neonatal Ed (2005) 1.02
The role of hyperoxia in the pathogenesis of experimental BPD. Semin Perinatol (2013) 1.02
Mechanisms of injury to the preterm lung and airway: implications for long-term pulmonary outcome. Neonatology (2012) 0.95
Lung development and the host response to influenza A virus are altered by different doses of neonatal oxygen in mice. Am J Physiol Lung Cell Mol Physiol (2012) 0.95
Role of reactive oxygen species in neonatal pulmonary vascular disease. Antioxid Redox Signal (2014) 0.91
Neonatal hyperoxia alters the host response to influenza A virus infection in adult mice through multiple pathways. Am J Physiol Lung Cell Mol Physiol (2013) 0.91
Less postnatal steroids, more bronchopulmonary dysplasia: a population-based study in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed (2006) 0.89
Accelerated thymic maturation and autoreactive T cells in bronchopulmonary dysplasia. Am J Respir Crit Care Med (2006) 0.89
Cardiorespiratory events in preterm infants: etiology and monitoring technologies. J Perinatol (2015) 0.88
Superoxide dismutase improves gas exchange and pulmonary hemodynamics in premature lambs. Am J Respir Crit Care Med (2005) 0.87
Developmental regulation of antioxidant enzymes and their impact on neonatal lung disease. Antioxid Redox Signal (2014) 0.87
Effects of a superoxide dismutase mimetic on biomarkers of lung angiogenesis and alveolarization during hyperoxia with intermittent hypoxia. Am J Transl Res (2013) 0.86
An update on pharmacologic approaches to bronchopulmonary dysplasia. Semin Perinatol (2013) 0.85
The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease. Antioxid Redox Signal (2014) 0.84
Prevention of bronchopulmonary dysplasia. Semin Fetal Neonatal Med (2009) 0.84
Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study. Pediatr Res (2012) 0.84
Bronchopulmonary dysplasia early changes leading to long-term consequences. Front Med (Lausanne) (2015) 0.82
Animal Models, Learning Lessons to Prevent and Treat Neonatal Chronic Lung Disease. Front Med (Lausanne) (2015) 0.82
Cumulative neonatal oxygen exposure predicts response of adult mice infected with influenza A virus. Pediatr Pulmonol (2014) 0.81
Antioxidant strategies and respiratory disease of the preterm newborn: an update. Oxid Med Cell Longev (2014) 0.81
Sildenafil therapy for bronchopulmonary dysplasia: not quite yet. J Perinatol (2012) 0.81
Neonatal hyperoxia increases sensitivity of adult mice to bleomycin-induced lung fibrosis. Am J Respir Cell Mol Biol (2012) 0.81
Superoxide dismutase 3 dysregulation in a murine model of neonatal lung injury. Am J Respir Cell Mol Biol (2014) 0.81
Prediction of respiratory outcome in extremely low gestational age infants. Neonatology (2015) 0.80
Performance of commonly used respiratory questionnaire items in a cohort of infants born preterm. Open J Pediatr (2013) 0.79
Antioxidants improve antibacterial function in hyperoxia-exposed macrophages. Free Radic Biol Med (2007) 0.79
Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide. J Pediatr (2015) 0.79
Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization. Antimicrob Agents Chemother (2014) 0.78
Affect of Early Life Oxygen Exposure on Proper Lung Development and Response to Respiratory Viral Infections. Front Med (Lausanne) (2015) 0.77
Current pharmacologic approaches for prevention and treatment of bronchopulmonary dysplasia. Int J Pediatr (2012) 0.77
Perinatal oxygen in the developing lung. Can J Physiol Pharmacol (2014) 0.76
Updates on Functional Characterization of Bronchopulmonary Dysplasia - The Contribution of Lung Function Testing. Front Med (Lausanne) (2015) 0.76
Elastase inhibitory activity of airway α1-antitrypsin is protected by treatment with a catalytic antioxidant in a baboon model of severe bronchopulmonary dysplasia. Pediatr Res (2011) 0.76
Update on the diagnosis and management of bronchopulmonary dysplasia/chronic lung disease of infancy: what the radiologist should know. Pediatr Radiol (2012) 0.76
Pharmacological options for BPD prevention: steps for better clinical trial design. J Perinatol (2014) 0.75
Drug therapy for the prevention and treatment of bronchopulmonary dysplasia. Front Pharmacol (2015) 0.75
Hyperoxia-induced p47phox activation and ROS generation is mediated through S1P transporter Spns2, and S1P/S1P1&2 signaling axis in lung endothelium. Am J Physiol Lung Cell Mol Physiol (2016) 0.75
Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 Regulates LPS-Induced Inflammation and Alveolar Remodeling in the Developing Lung. Am J Respir Cell Mol Biol (2016) 0.75
Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes. J Clin Med (2017) 0.75
An unanticipated benefit of the treatment of preterm infants with CuZn superoxide dismutase. Pediatrics (2003) 0.75
SOD2 activity is not impacted by hyperoxia in murine neonatal pulmonary artery smooth muscle cells and mice. Int J Mol Sci (2015) 0.75
The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age. J Pediatr (2017) 0.75
Developmental determinants and changing patterns of respiratory outcomes after preterm birth. Birth Defects Res A Clin Mol Teratol (2014) 0.75
Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns. J Pediatr (2016) 0.75
Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study. J Pediatr (2017) 0.75
Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr (2008) 5.19
The wealth of information conveyed by gestational age. J Pediatr (2005) 3.04
Limitations of model based dose selection for indacaterol in patients with chronic obstructive pulmonary disease. Int J Clin Pharmacol Ther (2012) 2.17
Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr (2009) 2.16
Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity. Neonatology (2013) 2.06
Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week. Pediatrics (2007) 2.06
Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics (2007) 1.53
Video and CD-ROM as a training tool for performing neurologic examinations of 1-year-old children in a multicenter epidemiologic study. J Child Neurol (2005) 1.49
Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns. MBio (2011) 1.42
A three-center, randomized, controlled trial of individualized developmental care for very low birth weight preterm infants: medical, neurodevelopmental, parenting, and caregiving effects. J Dev Behav Pediatr (2003) 1.36
Newborn screening showing decreasing incidence of cystic fibrosis. N Engl J Med (2008) 1.14
Association of Duchenne muscular dystrophy with autism spectrum disorder. J Child Neurol (2005) 1.04
Phase I trial and pharmacokinetic study of lexatumumab in pediatric patients with solid tumors. J Clin Oncol (2012) 0.99
Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation? Arch Dis Child Fetal Neonatal Ed (2010) 0.98
The clustering of disorders in infants born before the 28th week of gestation. Acta Paediatr (2010) 0.97
Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab. Cancer (2011) 0.94
Early blood gas abnormalities and the preterm brain. Am J Epidemiol (2010) 0.92
Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. Am J Respir Crit Care Med (2002) 0.88
Racial/ethnic differences in clinical and biochemical type 2 diabetes mellitus risk factors in children. Obesity (Silver Spring) (2013) 0.88
Prenatally diagnosed clubfeet: comparing ultrasonographic severity with objective clinical outcomes. J Pediatr Orthop (2010) 0.83
Cystic fibrosis newborn screening: using experience to optimize the screening algorithm. J Inherit Metab Dis (2010) 0.83
US assessment of estrogen-responsive organ growth among healthy term infants: piloting methods for assessing estrogenic activity. Pediatr Radiol (2010) 0.83
Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia. Genome Biol (2007) 0.82
Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions. J Pediatr (2005) 0.81
Reader variability in the use of diagnostic terms to describe white matter lesions seen on cranial scans of severely premature infants: the ELGAN study. J Clin Ultrasound (2010) 0.80
Risk factors and correlates of neonatal growth velocity in extremely low gestational age newborns: the ELGAN Study. Neonatology (2013) 0.79
Retinol binding protein 4 is associated with adiposity-related co-morbidity risk factors in children. J Pediatr Endocrinol Metab (2011) 0.79
Papillary carcinoma of the thyroid gland in a young child. Ultrasound Q (2004) 0.77
Prospective evaluation of a prenatal sonographic clubfoot classification system. Fetal Diagn Ther (2013) 0.75